The SELECT trial included participants with established cardiovascular disease, many in their 60s and 70s
10.1186/s13195-024-01666-7 15 DruckerD
The emerging evidence base summarised by Azento Health and encapsulated in Forte80shows that targeted probiotic therapy can stabilise the microbiome, cut side-effects and let patients stay the course
GLP-1 receptor agonists, such as Wegovy, which contain the active ingredient semaglutide, are a class of medications widely used for obesity and type 2 diabetes
Furthermore, we observed that GGCT was highly expressed in a dose-dependent manner in HCC and PCa cell lines both treated for 24 h (Fig
Another important component of the treatment with GLP-1RA is the inclusion of lifestyle interventions, including exercise and a low-calorie diet (1, 59)